STK11 and colorectal cancer: Higher expression of PARD3B is associated with colorectal cancer malignancy and poor survival, as PARD3B inhibits Lkb1/AMPK signaling pathway and its knockout induces apoptosis and reduces proliferation, supporting its role in colorectal cancer cell survival39,40.